IL-2 and Beyond in Cancer Immunotherapy.

about

IL-2 and Beyond in Cancer Immunotherapy.

Item

http://www.wikidata.org/entity/Q50004232

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

IL-2 and Beyond in Cancer Immunotherapy.

@en

IL-2 and Beyond in Cancer Immunotherapy.

@nl

type

Item

label

IL-2 and Beyond in Cancer Immunotherapy.

@en

IL-2 and Beyond in Cancer Immunotherapy.

@nl

prefLabel

IL-2 and Beyond in Cancer Immunotherapy.

@en

IL-2 and Beyond in Cancer Immunotherapy.

@nl

P1476

IL-2 and Beyond in Cancer Immunotherapy.

@en

P2093

Alicia Patterson

http://www.w3.org/2001/XMLSchema#string

C Bryce Johnson

http://www.w3.org/2001/XMLSchema#string

Chadrick E Denlinger

http://www.w3.org/2001/XMLSchema#string

Chrystal M Paulos

http://www.w3.org/2001/XMLSchema#string

Daniel J Neitzke

http://www.w3.org/2001/XMLSchema#string

David J Cole

http://www.w3.org/2001/XMLSchema#string

John M Wrangle

http://www.w3.org/2001/XMLSchema#string

Mark P Rubinstein

http://www.w3.org/2001/XMLSchema#string

Shikhar Mehrotra

http://www.w3.org/2001/XMLSchema#string

Zihai Li

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins

Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily

Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Adoptive immunotherapy for cancer: building on success

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

P304

45-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JIR.2017.0101

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29443657

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5815463

http://www.w3.org/2001/XMLSchema#string